Evaluation of Cytotoxicity and Apoptosis Induced by Coumarin Hydrazide-Hydrazone Derivatives in Human Hepatocellular Carcinoma Cell Line
DOI:
https://doi.org/10.48048/tis.2024.7628Keywords:
Coumarin, Hydrazide-hydrazone, Cytotoxicity, Apoptosis, AnticancerAbstract
Coumarin and aryl hydrazide-hydrazone have attracted our attention due to their vast biological properties. Previous studies suggested that coumarin-tethered aryl hydrazide-hydrazone showed potent activities against HepG2. In the present study, we investigated the cytotoxic potency of the coumarin derivatives 1 - 3 to compare with coumarin hydrazine-hydrazone hybrids 4 and 5 against hepatocellular carcinoma HepG2 and LH86 cell lines. Among the tested coumarins, hybrids 4 and 5 showed highly potent activity against HepG2 with IC50 values of 17.82 ± 2.79 and 7.87 ± 0.88 𝜇g/mL, respectively. The hybrid 4 also showed the strongest activity against LH86 cell line with IC50 values of 48.32 ± 2.64 𝜇g/mL. Further, we have studied the mechanism of action of the hybrid compounds 4 and 5 in HepG2 cells via the flow-cytometry analysis and the activation of the caspase-3 and caspase-7. The results showed that hybrids 4 and 5 obviously inhibited the proliferation of HepG2 cell line through inducing apoptosis.
HIGHLIGHTS
Focusing on coumarin and aryl hydrazide-hydrazone possess significant biological properties. We reported the preparation of coumarin hydrazine-hydrazone hybrids and evaluated their effects against hepatocellular carcinoma cell lines HepG2 and LH86. The hybrid compounds exhibited high potency against HepG2 and LH86. Flow-cytometry and caspase-3/7 expression analysis revealed that the hybrid compounds induced apoptosis in HepG2 cells.
GRAPHICAL ABSTRACT
Downloads
Metrics
References
JM Llovet, RK Kelley, A Villanueva, AG Singal, E Pikarsky, S Roayaie, R Lencioni, K Koike, J Zucman-Rossi and RS Finn. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2021; 7, 6.
Global Cancer Observatory. Cancer tomorrow, Available at: https://gco.iarc.fr/tomorrow/en/dataviz/trends?cancers=11, accessed July 2023.
CM Pfeffer and ATK Singh. Apoptosis: A target for anticancer therapy. Int. J. Mol. Sci. 2018; 19, 448.
RC Taylor, SP Cullen and SJ Martin. Apoptosis: Controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008; 9, 231.
M Nikolaou, A Pavlopoulou, AG Georgakilas and E Kyrodimos. The challenge of drug resistance in cancer treatment: A current overview. Clin. Exp. Metastasis 2018; 35, 309-18.
G Kirsch, AB Abdelwahab and P Chaimbault. Natural and synthetic coumarins with effects on inflammation. Molecules 2016; 21, 1322.
C Zaragozá, F Zaragozá, I Gayo-Abeleira and L Villaescusa. Antiplatelet activity of coumarins: In vitro assays on COX-1. Molecules 2021; 26, 3036.
R Nagamallu, B Srinivasan, MB Ningappa and AK Kariyappa. Synthesis of novel coumarin appended bis(formylpyrazole) derivatives: Studies on their antimicrobial and antioxidant activities. Bioorg. Med. Chem. Lett. 2016; 26, 690-4.
Z Li, D Kong, Y Liu and M Li. Pharmacological perspectives and molecular mechanisms of coumarinderivatives against virus disease. Gene. Dis. 2022; 9, 80-4.
F Salehian, H Nadri, L Jalili-Baleh, L Youseftabar-Miri, SNA Bukhari, A Foroumadi, TT Küçükkilinç, M Sharifzadeh and M Khoobi. A review: Biologically active 3,4-heterocycle-fused coumarins. Eur. J. Med. Chem. 2021; 212, 113034.
C Viegas-Junior, A Danuello, VD Silva Bolzani, EJ Barreiro and CA Fraga. Molecular hybridization: A useful tool in the design of new drug prototypes. Curr. Med. Chem. 2007; 14, 1829-52.
CG Arya, R Gondru, Y Li and J Banothu. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry. Eur. J. Med. Chem. 2022; 227, 113921.
MT Gabr, S Celik, S Akyuz and AE Ozel. Biological evaluation and pharmacokinetic profiling of a coumarin-benzothiazole hybrid as a new scaffold for human gliomas. Med. Drug Dis. 2020; 7, 100012.
V Prachayasittikul, R Pingaew, A Worachartcheewan, C Nantasenamat, S Prachayasittikul, S Ruchirawat and V Prachayasittikul. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives. Eur. J. Med. Chem. 2014; 84, 247-63.
Y Wang, W Zhang, J Dong and J Gao. Design, synthesis and bioactivity evaluation of coumarin-chalcone hybrids as potential anticancer agents. Bioorg. Chem. 2020; 95, 103530.
H Yu, Z Hou, Y Tian, Y Mou and C Guo. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents. Eur. J. Med. Chem. 2018; 151, 434-49.
M Holiyachi, SL Shastri, BM Chougala, NS Naik, V Pawar, LA Shastri, SD Joshi and VA Sunagar. Design and synthesis of new series of dipyrromethane-coumarin and porphyrin-coumarin derivatives: Excellent anticancer agents. J. Mol. Struct. 2021; 1237, 130424.
GS Lingaraju, KS Balaji, S Jayarama, SM Anil, KR Kiran and MP Sadashiva. Synthesis of new coumarin tethered isoxazolines as potential anticancer agents. Bioorg. Med. Chem. Lett. 2018; 28, 3606-12.
S Nayak, SL Gaonkar, EA Musad and AMAL Dawsar. 1,3,4-Oxadiazole-containing hybrids as potential anticancer agents: Recent developments, mechanism of action and structure-activity relationships. J. Saudi Chem. Soc. 2021; 25, 101284.
K Ostrowska. Coumarin-piperazine derivatives as biologically active compounds. Saudi Pharmaceut. J. 2020; 28, 220-32.
S Chantrapromma, P Ruanwas, B Jindawong and HK Fun. 1-Methyl-4-[(E)-2-(3-hydroxy-4-methoxyphen-yl)ethenyl]pyridinium 4-bromobenzenesulfonate monohydrate. Acta Crystallogr. 2019; E69, o1623-o1624.
TK Mohamed, RZ Batran, SA Elseginy, MM Ali and AE Mahmoud. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis. Bioorg. Chem. 2019; 85, 253-73.
M Sanduja, J Gupta, H Singh, PP Pagare and A Rana. Uracil-coumarin based hybrid molecules as potent anti-cancer and anti-bacterial agents. J. Saudi Chem. Soc. 2020; 24, 251-66.
L Zhang and Z Xu. Coumarin-containing hybrids and their anticancer activities. Eur. J. Med. Chem. 2019; 181, 111587.
T Al-Warhi, A Sabt, EB Elkaeed and WM Eldehna. Recent advancements of coumarin-based anticancer agents: An up-to-date review. Bioorg. Chem. 2020; 103, 104163.
A Dorababu. Coumarin-heterocycle framework: A privileged approach in promising anticancer drug design. Eur. J. Med. Chem. Rep. 2021; 2, 100006.
N Duangdee, W Mahavorasirikul and S Prateeptongkum. Design synthesis and anti-proliferative activity of some new coumarin substituted hydrazide-hydrazone derivatives. J. Chem. Sci. 2020; 132, 66.
S Prateeptongkum, N Duangdee and P Thongyoo. Facile iron(III) chloride hexahydrate catalyzed synthesis of coumarins. ARKIVOC 2015; 2015, 248-58.
L Panrit, T Plengsuriyakarn, P Martviset and K Na-Bangchang. Inhibitory activities of plumbagin on cell migration and invasion and inducing activity on cholangiocarcinoma cell apoptosis. Asian Pac. J. Trop. Med. 2018; 11, 430-35.
SS Taparia and A Khanna. Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines. Biomed. Pharmacother. 2016; 83, 130-40.
E Brauchle, S Thude, SY Brucker and K Schenke-Layland. Cell death stages in single apoptotic and necrotic cells monitored by Raman microspectroscopy. Sci. Rep. 2014; 4, 4698.
DR McIlwain, T Berger and TW Mak. Caspase functions in cell death and disease. Cold Spring Harbor Perspect. Biol. 2013; 5, a008656.
T Tomita. Apoptosis of pancreatic β-cells in type 1 diabetes. Bosnian J. Basic Med. Sci. 2017; 17, 183.
Y Zhang, X Chen, C Gueydan and J Han. Plasma membrane changes during programmed cell death. Cell Res. 2017; 28, 9-21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
